Search Results - "Cacic, P"

P667 Benefit of 5-ASA continuation on UC disease outcomes following initiation of a biologic by Tomasic, V, Biscanin, A, Cacic, P, Babic, F, Burcul, I, Dorosulic, Z, Kralj, D, Ogresta Kordej, D, Hrabar, D

“…Abstract Background In the era of advanced therapeutics for treatment of ulcerative colitis (UC) the benefit of routinely prescribed concomitant…”
Get full text

P513 Treatment persistence in bio-naive patients with long-standing Crohn’s disease treated with first-line biologics: real-life data from a Croatian tertiary center by Biscanin, A, Tomasic, V, Babic, F, Dorosulic, Z, Kralj, D, Cacic, P, Ogresta, D, Hrabar, D

“…Abstract Background All available biologics have demonstrated efficacy and safety as first-line treatment options for bio-naive Crohn’s disease (CD) patients…”
Get full text

P340 The association between colon pseudopolyps presence and clinical adverse events in UC patients treated with biologics by Tomasic, V, Biscanin, A, Cacic, P, Babic, F, Burcul, I, Siranovic Pongrac, I, Kralj, D, Dorosulic, Z, Ogresta Kordej, D, Hrabar, D

“…Abstract Background Colon pseudopolyps (aka post-inflammatory polyps) are potential marks of previous severe ulcerative colitis (UC) activity. The association…”
Get full text

P238 Enteropathy associated T-cell lymphoma as a diagnostic challenge in young patient with Crohn’s disease by Biscanin, A, Tomasic, V, Dorosulic, Z, Kralj, D, Lerotic, I, Cacic, P, Ogresta, D, Hrabar, D

“…Abstract Background The diagnosis of Crohn’s disease (CD) can sometimes be challenging. Enteropathy associated T cell lymphoma (EATL) is a rare aggressive…”
Get full text

P335 Utility of Intestinal Ultrasound in Monitoring Disease Activity in Ulcerative Colitis Patients Treated with Biologics by Tomašić, V, Kralj, D, Bišćanin, A, Ćaćić, P, Ogresta, D, Dorosulić, Z, Hrabar, D

“…Abstract Background Given the invasive nature and high cost of frequent and repeated endoscopies needed to monitor UC, search for non-invasive diagnostic…”
Get full text

P177 C-reactive protein/albumin ratio: a novel biomarker for monitoring of the disease activity in Ulcerative Colitis patients by Tomasic, V, Biscanin, A, Ćaćić, P, Palac, L, Dorosulic, Z, Kralj, D, Babic, F, Ogresta, D, Hrabar, D

“…Abstract Background Fecal calprotectin (FC) is a reliable laboratory test for non-invasive assessment of disease activity in ulcerative colitis (UC) patients;…”
Get full text

P565 Comparison of the efficacy of adalimumab and ustekinumab for prevention of intestinal fibrosis in bio-naive Crohn's Disease patients by Biscanin, A, Tomašić, V, Babic, F, Ćaćić, P, Ogresta Kordej, D, Hrabar, D, Kralj, D, Dorosulić, Z

“…Abstract Background Adalimumab (ADA) and ustekinumab (UST) are effective and efficient therapeutic options for patients with luminal Crohn's disease (CD)…”
Get full text

P657 Acceptability of a COVID-19 vaccine among cohort of Croatian IBD patients treated in tertiary IBD centre by Tomasic, V, Bišćanin, A, Ćaćić, P, Kralj, D, Dorosulić, Z, Ogresta, D, Hrabar, D

“…Abstract Background Several different types of COVID-19 vaccines are currently available in the EU. Although the massive prophylactic vaccination campaign is…”
Get full text

P369 Mycobacterium tuberculosis infection among patients with inflammatory bowel disease under biologics: experience of Croatian Tertiary Centre by Ogresta, D, Bišćanin, A, Tomašić, V, Dorosulić, Z, Kralj, D, Forgač, J, Ćaćić, P, Lerotić, I, Hrabar, D

“…Abstract Background Mycobacterium tuberculosis infection (TB) causes a huge number of deaths in the world. A majority (95%) of infections remain asymptomatic,…”
Get full text

P765 Fatigue as one of the most important symptoms in adult patients with inflammatory bowel disease: Croatian tertiary centre pilot study by Ćaćić, P, Tomašić, V, Kralj, D, Bišćanin, A, Dorosulić, Z, Lerotić, I, Ogresta, D, Forgač, J, Hrabar, D

“…Abstract Background Although there have been revolutionary improvements in care of IBD patients, considering the effect of lifelong disease with numerous…”
Get full text